Home » Keywords » adhansia-xr

Items Tagged with 'adhansia-xr'

ARTICLES

In Brief: A 16-Hour Ritalin

October 3, 2019

Chris Aiken, MD

Adhansia XR is a new extended-release methylphenidate. Its distinguishing feature is its 16-hour duration.

FDA Approves Adhansia XR

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

Talia Puzantian, PharmD, BCPP Joshua Feder, MD Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this article we discuss a newly FDA-approved formulation for ADHD. Adhansia XR, is a new formulation of extended-release methylphenidate approved by the FDA for the treatment of ADHD in patients 6 years and older.

Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Geriatric Psychiatry Fact Book, First Edition (2025)
Everything you need to help your older adult patients from the unbiased clinical experts who...
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

Child Psychiatry
Understanding Climate Anxiety in Youth
More teens are saying they can’t sleep because they’re worried about the environment. Today, we’re asking: How do we respond to climate anxiety without pathologizing it?

Listen now